Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Bondada Engineering Q4 FY25: Order Book ₹5,044 Cr | Arthneeti
Q4 FY25
500-600 crores annually by 2030 from around Rs. Key concall takeaways from Bondada Engineering Ltd's Q4 FY25 earnings call — and how it ranks against sector…
5 Aug 2026
Jupiter Life Line Hospitals Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Total income grew 9.8% YoY in Q3 FY26, mainly driven by ARPOB growth (~10% this quarter). Key concall takeaways from Jupiter Life Line Hospitals Ltd's Q3 FY26…
5 Aug 2026
Jupiter Life Line Hospitals Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
ARPOB (Average Revenue Per Occupied Bed) improved ~15% in H1 FY26 driven by case mix optimization and rate revisions. Key concall takeaways from Jupiter Life…
5 Aug 2026
Jupiter Life Line Hospitals Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Overall volume growth had been around 10% year-on-year in IPD and OPD segments, contributing to ~17-18% revenue growth previously. Key concall takeaways from…
5 Aug 2026
Aeroflex Industries Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Aeroflex has already received orders for the cooling product worth approximately INR16 crores (two orders of about INR8 crores each). Key concall takeaways…
5 Aug 2026
TVS Supply Chain Solutions Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
TVS Supply Chain Solutions reports an order pipeline of approximately INR 6,200 crores. Key concall takeaways from TVS Supply Chain Solutions Ltd's Q2 FY26…
5 Aug 2026
TVS Supply Chain Solutions Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
The Network Solutions (NS) segment showed strong growth (~17% in 9 months FY '25) and continues on an upward trajectory. Key concall takeaways from TVS Supply…
5 Aug 2026
NIIT Learning Systems Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
AI-enabled services, contributing nearly 10% of current revenue, may provide margin benefits over the medium term. Key concall takeaways from NIIT Learning…
5 Aug 2026
NIIT Learning Systems Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Sector-wise, management consulting and professional services showed 25%+ Q-o-Q revenue growth, with green shoots in L&D spending by Big 4 firms. Key concall…
5 Aug 2026
Flair Writing Industries Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Flomaxe OEM business contributed INR 6 crore, indicating ongoing orders in that segment. Key concall takeaways from Flair Writing Industries Ltd's Q3 FY26…
5 Aug 2026
Flair Writing Industries Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Creative segment: Rapid growth with 70% YoY increase in Q2 FY '26; expanding product portfolio (237 products) and distribution; growth momentum to continue…
5 Aug 2026
Flair Writing Industries Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Reported profit after tax (PAT) increased 10.5% year-on-year in Q1 FY '26; PAT margin stands at 10%. Key concall takeaways from Flair Writing Industries Ltd's…
5 Aug 2026
Jio Financial Services Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Jio Financial Services (JFSL) shows strong growth momentum with consolidated total income rising 48% YoY to Rs. Key concall takeaways from Jio Financial…
5 Aug 2026
Jio Financial Services Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
75 crore vs Q2 FY25 Rs. Key concall takeaways from Jio Financial Services Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
5 Aug 2026
Concord Biotech Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Injectables contributing around 6% growth over the next 3-5 years. Key concall takeaways from Concord Biotech Ltd's Q3 FY26 earnings call — and how it ranks…
5 Aug 2026
Concord Biotech Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
. Key concall takeaways from Concord Biotech's Q2 FY26 earnings call — and how it ranks against sector peers.
5 Aug 2026
SBFC Finance Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
SBFC Finance Limited currently has a diversified borrowing profile including around 50% bank borrowings, increased borrowings from NCD markets, and signed…
5 Aug 2026
SBFC Finance Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Disbursals grew by about 30% Y-o-Y and 7% Q-o-Q as of June 2025, with a run rate supporting around 20% growth year-on-year (Page 8). Key concall takeaways from…
5 Aug 2026
SBFC Finance Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Management noted potential to accelerate growth beyond 7% if the market opens up and underwriting standards are relaxed, but currently remain cautious. Key…
5 Aug 2026
Yatharth Hospital & Trauma Care Services Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Existing hospitals showing strong growth; Q3 FY '26 revenue up 46% YoY and 15% QoQ, driven by existing hospitals growing 33% YoY. Key concall takeaways from…
5 Aug 2026